These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1816731)

  • 1. Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
    Coster JM
    Alaska Med; 1991; 33(4):147-50. PubMed ID: 1816731
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
    Coster JM
    J Med Assoc Ga; 1991 Apr; 80(4):225-9. PubMed ID: 1861125
    [No Abstract]   [Full Text] [Related]  

  • 3. Prior authorization made simple.
    Owen JA
    Va Med Q; 1993; 120(4):184-5. PubMed ID: 8251554
    [No Abstract]   [Full Text] [Related]  

  • 4. Unintended outcomes of medicaid drug cost-containment policies on the chronically mentally ill.
    Soumerai S
    J Clin Psychiatry; 2003; 64 Suppl 17():19-22. PubMed ID: 14680423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs.
    Tieman J
    Mod Healthc; 2002 Apr; 32(17):28-31. PubMed ID: 12024771
    [No Abstract]   [Full Text] [Related]  

  • 6. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug companies crying foul over Medicaid's formulary push.
    Carroll J
    Manag Care; 2002 Nov; 11(11):12-4. PubMed ID: 12491852
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling the cost of prescription drugs.
    White JR
    Health Prog; 1992 Mar; 73(2):12-4, 25. PubMed ID: 10116498
    [No Abstract]   [Full Text] [Related]  

  • 12. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expect calls from pharmacists as DUR process gears up.
    Owen JA
    Va Med Q; 1993; 120(1):31. PubMed ID: 8420566
    [No Abstract]   [Full Text] [Related]  

  • 14. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription charges.
    Birch S
    J R Coll Gen Pract; 1986 Oct; 36(291):473. PubMed ID: 3440993
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicaid caps. Implications for ambulatory services in academic medical centers.
    Hershey CO; Lanham RJ; Colligan NR; Fudyma JR; Policastro DJ; Tapolyai M; Farlow PM; Poss J
    Med Care; 1995 Jan; 33(1):119-25. PubMed ID: 7823643
    [No Abstract]   [Full Text] [Related]  

  • 17. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid program; prescription drugs. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Jul; 72(136):39141-245. PubMed ID: 17674494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the potential link between Medicaid access restrictions, physician location, and health disparities.
    Headen A; Masia N
    Am J Manag Care; 2005 Jan; 11 Spec No():SP21-6. PubMed ID: 15700906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.